ProQR Therapeutics' IPO

ProQR Therapeutics raised a round of funding on September 18, 2014. Investors include Public.

ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders.…

Articles about ProQR Therapeutics' IPO: